5.08
0.36 (7.63%)
0.36 (7.63%)
Upgrade to Real-Time
Afterhours
Best deals to access real time data! |
|
CHART Trader
Monthly Subscription
for only
|
|
Canadian Level 1 + USA
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Adamas Pharmaceuticals Inc | ADMS | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| 0.36 | 7.63% | 5.08 | 16:00:10 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 5.00 | 4.81 | 5.25 | 5.08 | 4.72 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 5.00 | 5.12 | 0.12 | - | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 3,292 | 700,040 | $ 4.98 | $ 3,487,855 | 171,722 | 1.90 - 6.15 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:00:06 | formt | 947 | $ 5.08 | USD |
Adamas Pharmaceuticals Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 144.88M | 28.52M | 23.75M | $ 54.64M | $ -40.00M | -3.80 | -2.10 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
Adamas Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ADMS Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 4.49 | 5.25 | 4.38 | 4.60 | 135,387 | 0.59 | 13.14% |
| 1 Month | 4.62 | 5.25 | 4.11 | 4.57 | 143,282 | 0.46 | 9.96% |
| 3 Months | 3.09 | 5.40 | 3.05 | 4.45 | 168,535 | 1.99 | 64.4% |
| 6 Months | 2.60 | 5.55 | 2.4301 | 4.43 | 327,051 | 2.48 | 95.38% |
| 1 Year | 5.13 | 6.15 | 1.90 | 3.81 | 348,578 | -0.05 | -0.97% |
| 3 Years | 40.71 | 41.74 | 1.90 | 12.72 | 524,436 | -35.63 | -87.52% |
| 5 Years | 21.65 | 44.00 | 1.90 | 15.99 | 479,490 | -16.57 | -76.54% |
Adamas Pharmaceuticals Description
| Adamas Pharmaceuticals Inc discovers, develops, and sells therapies for chronic neurologic disorders. The company's approved/commercial product is GOCOVRI, an amantadine therapy for the treatment of levodopa-induced dyskinesia in patients with Parkinson's disease. It operates in one reportable segment: the development and commercialization of therapeutics targeting chronic disorders of the central nervous system. The company generates its revenues primarily from the United States. |
